Cargando…
Mesenchymal Stem Cells: New Players in Retinopathy Therapy
Retinopathies in human and animal models have shown to occur through loss of pericytes resulting in edema formation, excessive immature retinal angiogenesis, and neuronal apoptosis eventually leading to blindness. In recent years, the concept of regenerating terminally differentiated organs with a c...
Autor principal: | Rajashekhar, Gangaraju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006021/ https://www.ncbi.nlm.nih.gov/pubmed/24795699 http://dx.doi.org/10.3389/fendo.2014.00059 |
Ejemplares similares
-
Adult Stem Cell Therapeutics in Diabetic Retinopathy
por: Gaddam, Sriprachodaya, et al.
Publicado: (2019) -
Mesenchymal Stem Cell Induced Foxp3(+) Tregs Suppress Effector T Cells and Protect against Retinal Ischemic Injury
por: Agrawal, Mona, et al.
Publicado: (2021) -
Prolactin and vasoinhibin are endogenous players in diabetic retinopathy revisited
por: Triebel, Jakob, et al.
Publicado: (2022) -
Modulation of Mesenchymal Stem Cells for Enhanced Therapeutic Utility in Ischemic Vascular Diseases
por: Elshaer, Sally L., et al.
Publicado: (2021) -
Emerging Antioxidant Paradigm of Mesenchymal Stem Cell-Derived Exosome Therapy
por: Xia, Chen, et al.
Publicado: (2021)